Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Direct Quantitative Bisulfite Sequencing Using Tag-modified Primers and Internal Normalization

DIMO DIETRICH
Anticancer Research December 2016, 36 (12) 6343-6346;
DIMO DIETRICH
1Institute of Pathology, University Hospital Bonn, Bonn, Germany
2Department of Otolaryngology, Head and Neck Surgery, University Hospital Bonn, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dimo.dietrich{at}gmail.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

For the investigation of DNA methylation patterns, bisulfite conversion of the DNA followed by polymerase chain reaction (PCR) amplification and sequencing of the region of interest is the method of choice when information at single CpG site resolution is desired. In this study, a simple method for direct quantitative bisulfite sequencing based on the Sanger method is shown to be usable for the accurate analysis of single CpG sites. This method is based on the usage of tag-modified primers to obtain an internal normalization signal within the PCR product.

  • DNA methylation
  • direct quantitative bisulfite sequencing
  • internal normalization
  • Sanger method

DNA methylation alterations are among the most promising candidates for cancer biomarker research. Sequencing of bisulfite DNA is the preferred method when detailed information on the methylation pattern of a given template is desired at single CpG resolution. Currently, bisulfite sequencing based on the chain-termination reaction developed by Sanger and co-workers is among the most commonly used methods for methylation analysis (1, 2). Quantification of methylation is usually carried out by cloning of the polymerase chain reaction (PCR) product followed by sequencing a number of individual clones. Therefore, the resolution directly correlates with the number of analyzed clones, which is time consuming and expensive when a high resolution is desired. A more cost-efficient and faster approach is achieved by direct sequencing of the PCR product without any cloning steps (3). This approach provides a quantitative measure of the degree of methylation at a particular target site by comparing cytosine and thymine signals. However, it is susceptible to basecaller artefacts and therefore limited in its resolution. Other technologies, such as pyrosequencing (4, 5), also allow for the quantitative analysis of single CpG sites, but the required instruments are less commonly available in many laboratories.

Thus, inexpensive and simple methods for the accurate quantification of single CpG sites with direct bisulfite sequencing using standard laboratory equipment, such as capillary electrophoresis instruments, would offer a significant improvement for DNA methylation analysis.

Here, an improved method for quantitative bisulfite sequencing of single CpG sites based on the Sanger method is presented. Accurate quantification is achieved by the incorporation of a domain into the PCR product, which is subsequently used for signal normalization (6).

Materials and Methods

Unmethylated DNA was prepared by multiple displacement amplification (MDA), a genome-wide amplification method (7). For the preparation of DNA mixtures with defined methylation ratios, a portion of the MDA amplificate was treated with SssI methyltransferase (New England Biolabs, Ipswich, MA, USA) in the presence of S-adenosyl-methionine, according to the manufacturer's instructions, and mixed with the unmethylated amplificate to give mixtures representing 0, 5, 10, 15, 25, 50, 75 and 100% methylation. Two micrograms of each of these mixtures were bisulfite treated using the EpiTect® kit (Qiagen, Hilden, Germany). The resulting bisulfite DNA concentration was determined by UV spectrophotometry using a Nanodrop® ND-1000 spectral photometer (Nanodrop Technologies, Wilmington, DE, USA).

PCR amplification was carried out at 25 μl scale (10 ng DNA, 1 U HotStar Taq polymerase (Qiagen), 1 x PCR buffer (Qiagen), 0.2 mM each dNTP (Fermentas, Burlington, Canada), 0.5 μM both primers (reverse primer: aggtgTTCTAATCCTCCTTTCCACAATAA, forward primer: GTAGGGGAGGGAAGTAGATGTT; the normalization domain is indicated using lower case letters). Incubation was performed using the following temperature profile: 15 min at 95°C and 45 cycles with 20 s at 95°C, 45 s at 58°C and 30 s at 72°C. Sequencing was carried as previously described (6). Raw data were extracted from the ABI sequencing electropherograms using BioEdit 6.0.7 software (Isis Pharmaceuticals, Inc., Carlsbad, CA, USA). The trace containing the methylation information was visualized and the normalization signal identified. Electropherograms were aligned using the normalization signals in the primer tails. The signals were normalized by integrating the signals of the normalization domain and by dividing each data point of the electropherogram by this reference value. Thirty data points surrounding each identified peak maximum within each trace were integrated to obtain the methylation score for the respective CpG.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Principle of signal normalization. Sequence electropherograms (cytosine traces only) from five mixtures of methylated and unmethylated DNA (0, 5, 15, 50, and 100% methylated DNA) before (A) and after (B) signal normalization. Normalization is achieved by dividing the intensity by the area of the normalization signal.

Results

The principle of the signal normalization is shown in Figure 1. The cytosine traces containing the methylation information from five different methylated DNA mixtures are shown before (Figure 1A) and after normalization (Figure 1B). The normalization signal was derived from the three cytosines, which were incorporated into the PCR product. After normalization, the peak areas (and heights) at the CpG sites of interest were found to correlate with the relative methylation of the template DNA.

The methylation of five single CpG sites within the promoter region of the PITX2 gene was analyzed in order to demonstrate the power of the direct quantitative bisulfite sequencing method. For this purpose, DNA mixtures of unmethylated and methylated DNA were prepared and analyzed. The paired-like homeodomain 2 (PITX2) gene was chosen since it represents one of the best validated DNA methylaion biomarkers in various types of cancer (8-11, 13, 14). The results of the analysis of five CpG sites within the PITX2 gene are illustrated in Figure 2. The areas of the normalized methylation signals correlated well with the methylation of the applied DNA mixture for each of the five CpG sites (Figure 2). All seven mixtures (0, 5, 10, 25, 50, 75 and 100%) were clearly distinguishable.

Discussion

DNA methylation biomarkers have shown promising results in the clinical management of cancer. Most methodologies used to assess the methylation status of a certain gene locus are based on preceding bisulfite conversion of the DNA. Bisulfite treatment of the template DNA leads to deamination of unmethylated cytosines to uracil, leaving only methylated cytosines unaltered (15). Thus, the converted DNA only contains cytosines at positions which were originally methylated.

Amplification of the converted DNA using reverse primers containing guanosines at their 5’ end leads to the incorporation of cytosines into the PCR product. These additional cytosines at the 3’ end of the PCR product are present in each molecule of the PCR product and therefore behave like completely methylated CpG sites. Thus, they can be used as an internal reference signal for normalization. Similarly, the incorporation of the normalization signal can also be achieved using modified forward primers containing cytosines at their 5’ end and a subsequent sequencing via the reverse primer.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Correlation of normalized peak areas and relative methylation of the template DNA. Normalized peak areas are shown of five single CpG sites resulting from the sequencing of seven different mixtures of methylated and unmethylated DNA (0, 5, 10, 25, 50, 75 and 100% methylated DNA). The normalized and integrated intensities are scaled from 0% to 100% in order to enable a direct comparison of the five single CpG sites.

The results of the quantitative bisulfite sequencing method are presented as normalized peak areas. In order to yield the percentage of methylation, these peak areas have to be transformed into the percentage of methylation based on calibration curves. Such calibration curves are prepared applying DNA mixtures with known percentages of methylation. The challenge of preparing suitable calibration mixtures is in the use of DNAs, which are on the one hand completely methylated and completely unmethylated, respectively, and which on the other hand exhibit a symmetric representation of the analyzed locus. MDA DNA is partially single stranded and therefore it is not possible to methylate MDA DNA completely using methyltransferases. However, it is not possible to mix this DNA with completely methylated DNA of natural origin since the loci are not represented symmetrically (16). DNA from sperm bears the potential to be a DNA of natural origin, which should have no major chromosomal re-arrangements and has been reported to be unmethylated at many loci (17). Therefore, DNA from sperm and enzymatically methylated equivalents thereof might be suitable for preparing calibration mixtures.

In addition, the usage of a calibration curve allows for a normalization of a PCR bias, i.e. preferred amplification of methylated DNA (18). A PCR bias might result in a deviation from linearity of a response curve as seen in Figure 2.

In this study, it has been shown that the presented method for direct quantitative bisulfite sequencing based on the Sanger method is a simple, affordable and powerful tool for the accurate quantification of methylation of single CpG sites using standard laboratory equipment, such as capillary electrophoresis instruments.

  • Received September 27, 2016.
  • Revision received October 13, 2016.
  • Accepted October 14, 2016.
  • Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Liu L,
    2. Wylie RC,
    3. Hansen NJ,
    4. Andrews LG,
    5. Tollefsbol TO
    : Profiling DNA methylation by bisulfite genomic sequencing: problems and solutions. Methods Mol Biol 287: 169-179, 2004.
    OpenUrlPubMed
  2. ↵
    1. Fraga MF,
    2. Esteller M
    : DNA methylation: a profile of methods and applications. Biotechniques 33: 632-649, 2002.
    OpenUrlPubMed
  3. ↵
    1. Lewin J,
    2. Schmitt AO,
    3. Adorján P,
    4. Hildmann T,
    5. Piepenbrock C
    : Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics 20: 3005-3012, 2004.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Tost J,
    2. Dunker J,
    3. Gut IG
    : Analysis and quantification of multiple methylation variable positions in CpG islands by pyrosequencing. Biotechniques 35: 152-156, 2003.
    OpenUrlPubMed
  5. ↵
    1. Tost J,
    2. Gut IG
    : DNA methylation analysis by pyrosequencing. Nat Protoc 2: 2265-2275, 2007.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Dietrich D,
    2. Lesche R,
    3. Tetzner R,
    4. Krispin M,
    5. Dietrich J,
    6. Haedicke W,
    7. Schuster M,
    8. Kristiansen G
    : Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues. J Histochem Cytochem 57: 477-489, 2009.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Dean FB,
    2. Hosono S,
    3. Fang L,
    4. Wu X,
    5. Faruqi AF,
    6. Bray-Ward P,
    7. Sun Z,
    8. Zong Q,
    9. Du Y,
    10. Du J,
    11. Driscoll M,
    12. Song W,
    13. Kingsmore SF,
    14. Egholm M,
    15. Lasken RS
    : Comprehensive human genome amplification using multiple displacement amplification. Proc Natl Acad Sci USA 99: 5261-5266, 2002.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Sailer V,
    2. Holmes EE,
    3. Gevensleben H,
    4. Goltz D,
    5. Dröge F,
    6. de Vos L,
    7. Franzen A,
    8. Schröck F,
    9. Bootz F,
    10. Kristiansen G,
    11. Schröck A,
    12. Dietrich D
    : PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma. Oncotarget doi: 10.18632/oncotarget.12417.
    1. Maier S,
    2. Nimmrich I,
    3. Koenig T,
    4. Eppenberger-Castori S,
    5. Bohlmann I,
    6. Paradiso A,
    7. Spyratos F,
    8. Thomssen C,
    9. Mueller V,
    10. Nährig J,
    11. Schittulli F,
    12. Kates R,
    13. Lesche R,
    14. Schwope I,
    15. Kluth A,
    16. Marx A,
    17. Martens JW,
    18. Foekens JA,
    19. Schmitt M,
    20. Harbeck N,
    21. European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group
    : DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients – Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group. Eur J Cancer 43: 1679-1686, 2007.
    OpenUrlCrossRefPubMed
    1. Nimmrich I,
    2. Sieuwerts AM,
    3. Meijer-van Gelder ME,
    4. Schwope I,
    5. Bolt-de Vries J,
    6. Harbeck N,
    7. Koenig T,
    8. Hartmann O,
    9. Kluth A,
    10. Dietrich D,
    11. Magdolen V,
    12. Portengen H,
    13. Look MP,
    14. Klijn JG,
    15. Lesche R,
    16. Schmitt M,
    17. Maier S,
    18. Foekens JA,
    19. Martens JW
    : DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients. Breast Cancer Res Treat 111: 429-437, 2008.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Harbeck N,
    2. Nimmrich I,
    3. Hartmann A,
    4. Ross JS,
    5. Cufer T,
    6. Grützmann R,
    7. Kristiansen G,
    8. Paradiso A,
    9. Hartmann O,
    10. Margossian A,
    11. Martens J,
    12. Schwope I,
    13. Lukas A,
    14. Müller V,
    15. Milde-Langosch K,
    16. Nährig J,
    17. Foekens J,
    18. Maier S,
    19. Schmitt M,
    20. Lesche R
    : Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients. J Clin Oncol 26: 5036-5042, 2008.
    OpenUrlAbstract/FREE Full Text
    1. Hartmann O,
    2. Spyratos F,
    3. Harbeck N,
    4. Dietrich D,
    5. Fassbender A,
    6. Schmitt M,
    7. Eppenberger-Castori S,
    8. Vuaroqueaux V,
    9. Lerebours F,
    10. Welzel K,
    11. Maier S,
    12. Plum A,
    13. Niemann S,
    14. Foekens JA,
    15. Lesche R,
    16. Martens JW
    : DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. Clin Cancer Res 15: 315-323, 2009.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Dietrich D,
    2. Hasinger O,
    3. Liebenberg V,
    4. Field JK,
    5. Kristiansen G,
    6. Soltermann A
    : DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients. Diagn Mol Pathol 21: 93-104, 2012.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Bañez LL,
    2. Sun L,
    3. van Leenders GJ,
    4. Wheeler TM,
    5. Bangma CH,
    6. Freedland SJ,
    7. Ittmann MM,
    8. Lark AL,
    9. Madden JF,
    10. Hartman A,
    11. Weiss G,
    12. Castaños-Vélez E
    : Multicenter clinical validation of PITX2 methylation as a prostate-specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer. J Urol 184: 149-56, 2010.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Frommer M,
    2. McDonald LE,
    3. Millar DS,
    4. Collis CM,
    5. Watt F,
    6. Grigg GW,
    7. Molloy PL,
    8. Paul CL
    : A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89: 1827-1831, 1992.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Arriola E,
    2. Lambros MB,
    3. Jones C,
    4. Dexter T,
    5. Mackay A,
    6. Tan DS,
    7. Tamber N,
    8. Fenwick K,
    9. Ashworth A,
    10. Dowsett M,
    11. Reis-Filho JS
    : Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisation. Lab Invest 87: 75-83, 2007.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Rakyan VK,
    2. Down TA,
    3. Thorne NP,
    4. Flicek P,
    5. Kulesha E,
    6. Gräf S,
    7. Tomazou EM,
    8. Bäckdahl L,
    9. Johnson N,
    10. Herberth M,
    11. Howe KL,
    12. Jackson DK,
    13. Miretti MM,
    14. Fiegler H,
    15. Marioni JC,
    16. Birney E,
    17. Hubbard TJ,
    18. Carter NP,
    19. Tavaré S,
    20. Beck S
    : An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res 18: 1518-1529, 2008.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Warnecke PM,
    2. Stirzaker C,
    3. Melki JR,
    4. Millar DS,
    5. Paul CL,
    6. Clark SJ
    : Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic Acids Res 25: 4422-4426, 1997.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 36, Issue 12
December 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Direct Quantitative Bisulfite Sequencing Using Tag-modified Primers and Internal Normalization
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Direct Quantitative Bisulfite Sequencing Using Tag-modified Primers and Internal Normalization
DIMO DIETRICH
Anticancer Research Dec 2016, 36 (12) 6343-6346;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Direct Quantitative Bisulfite Sequencing Using Tag-modified Primers and Internal Normalization
DIMO DIETRICH
Anticancer Research Dec 2016, 36 (12) 6343-6346;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
  • Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
  • Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells
Show more Experimental Studies

Keywords

  • DNA methylation
  • direct quantitative bisulfite sequencing
  • internal normalization
  • Sanger method
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire